Lipoprotein(a) Concentrations Are Independent of Polygenic Score for Coronary Artery Disease
Open Access
- 25 December 2023
- journal article
- Published by Elsevier in JACC: Advances
- Vol. 3 (2)
Abstract
No abstract availableFunding Information
- Novartis Pharmaceuticals Corporation (7089)
- National Heart, Lung, and Blood Institute
- National Human Genome Research Institute (1U01HG011719)
This publication has 5 references indexed in Scilit:
- A multi-ancestry polygenic risk score improves risk prediction for coronary artery diseaseNature Medicine, 2023
- Clinical Utility of Lipoprotein(a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular DiseaseJAMA Cardiology, 2021
- Lipoprotein(a) Reduction in Persons with Cardiovascular DiseaseNew England Journal of Medicine, 2020
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular DiseaseJACC, 2019
- The UK Biobank resource with deep phenotyping and genomic dataNature, 2018